We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress
Sign In
Advertise with Us
PURITAN MEDICAL

Download Mobile App




Urinary Round Cells Predict Need For Hemodialysis

By LabMedica International staff writers
Posted on 28 Jun 2016
Print article
Image: A photomicrograph of (#1) a round cell in urine sediment Sternheimer stain; (#2) a hyaline cast; (#3) and a macrophage (Photo courtesy of the University of Tokyo).
Image: A photomicrograph of (#1) a round cell in urine sediment Sternheimer stain; (#2) a hyaline cast; (#3) and a macrophage (Photo courtesy of the University of Tokyo).
Urinalysis is a safe, easy, and cost-effective diagnostic tool, and sediments are indicative of nephron condition, therefore, it can be considered as a virtual renal biopsy and is useful for the differential diagnosis of acute kidney injury and chronic kidney disease.

Voided urine contains a variety of cells from the kidney and urinary tract and urinalysis provides diverse information when the cellular components are investigated. However, not all cells in the urine have been characterized and the origins of cells have not been determined in some cases.

Scientists at the School of Medicine, The University of Tokyo (Japan) and their colleagues collected spot urine samples from 372 patients, 278 males and 94 females. Male patients were 68.4 years on average, range 30 to 95 years and females were 67.9 years on average, range 26 to 89. A total of 247 cases had diabetes and 125 did not have diabetes were included in the study.

Urine sediments were prepared and examined following a previously defined method. Round cells were counted at 100 × magnification in whole-field (WF) view and scored as negative, 1–4/WF, 5–9/WF, or greater than 10/WF. Serum creatinine estimated at two years and six months before the examination, on the day of examination and six months after the examination were compared with the round cells scores. Urine sediment was prepared for immunohistochemistry using Smear Gell (GenoStaff, Tokyo, Japan) processed and immunofluorescence staining was observed under a fluorescence microscope, BZ-X700 (Keyence, Osaka, Japan). Ribonucleic acid (RNA) extraction and quantitative real-time reverse transcription-polymerase chain reaction were performed on sediment cells, which were also cultured.

The scientists found ‘round cell’ to be distinct from known cells in sediment and is close to proximal convoluted tubule-derived cells based on morphology and molecular marker expression Gamma-Glutamyltransferase 1 (GGT1) but not podocalyxin. Also it was positive for undifferentiated cell markers, including Paired box gene 2 (PAX2), Wilms Tumor 1 (WT1), Odd-Skipped Related Transcription Factor 1(OSR1), and SIX Homeobox 2 (SIX2). They were observed in end-stage renal failure patients and the number of cells was correlated with the severity of chronic kidney disease. A prospective analysis revealed that patients who had more round cells were more likely to require hemodialysis within a year.

The authors concluded that the novel round cell is close to tubular epithelial cells and expresses undifferentiated cell markers. Round cells can be substantially detected in advanced renal failure and could be a novel marker for kidney death within a year for both in diabetic and non-diabetic kidney disease. The study was published on June 1, 2016, in the journal Clinica Chimica Acta.

Related Links:
School of Medicine, The University of Tokyo
GenoStaff
Keyence
Platinum Member
COVID-19 Rapid Test
OSOM COVID-19 Antigen Rapid Test
Magnetic Bead Separation Modules
MAG and HEATMAG
Complement 3 (C3) Test
GPP-100 C3 Kit
New
Gold Member
TORCH Panel Rapid Test
Rapid TORCH Panel Test

Print article

Channels

Molecular Diagnostics

view channel
Image: A blood test could predict lung cancer risk more accurately and reduce the number of required scans (Photo courtesy of 123RF)

Blood Test Accurately Predicts Lung Cancer Risk and Reduces Need for Scans

Lung cancer is extremely hard to detect early due to the limitations of current screening technologies, which are costly, sometimes inaccurate, and less commonly endorsed by healthcare professionals compared... Read more

Hematology

view channel
Image: The CAPILLARYS 3 DBS devices have received U.S. FDA 510(k) clearance (Photo courtesy of Sebia)

Next Generation Instrument Screens for Hemoglobin Disorders in Newborns

Hemoglobinopathies, the most widespread inherited conditions globally, affect about 7% of the population as carriers, with 2.7% of newborns being born with these conditions. The spectrum of clinical manifestations... Read more

Immunology

view channel
Image: Exosomes can be a promising biomarker for cellular rejection after organ transplant (Photo courtesy of Nicolas Primola/Shutterstock)

Diagnostic Blood Test for Cellular Rejection after Organ Transplant Could Replace Surgical Biopsies

Transplanted organs constantly face the risk of being rejected by the recipient's immune system which differentiates self from non-self using T cells and B cells. T cells are commonly associated with acute... Read more

Pathology

view channel
Image: Comparison of traditional histopathology imaging vs. PARS raw data (Photo courtesy of University of Waterloo)

AI-Powered Digital Imaging System to Revolutionize Cancer Diagnosis

The process of biopsy is important for confirming the presence of cancer. In the conventional histopathology technique, tissue is excised, sliced, stained, mounted on slides, and examined under a microscope... Read more
Copyright © 2000-2024 Globetech Media. All rights reserved.